The Company has scheduled a conference call for analysts and investors on Wednesday, May 27, 2026 at 04:30 PM (IST) to discuss the Audited Financial Results (Standalone and Consolidated) ....
MARKSANS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Marksans Pharma Ltd has scheduled an earnings conference call for Wednesday, May 27, 2026 at 04:30 PM IST to discuss the Audited Financial Results (Standalone and Consolidated) for Q4FY26 and the year ended March 31, 2026. The call will feature Mr. Mark Saldanha (Founder, Chairman and Managing Director) and Mr. Jitendra Sharma (CFO). DAM Capital Advisors is organizing the call, and dial-in details are provided for global access. The company will host the presentation, audio recording, and transcript on its website after the call.
This is a routine earnings call announcement with no material disclosures. Shareholders can use this opportunity to hear management discuss Q4FY26 performance, but no new financial data or guidance is being released at this time.